BIIB Biogen Inc.
Healthcare
Price
$205.02
Intrinsic value
$84.09
Buy price
$67.27
Discount
-143.8%
DCF walkthrough
Near-term growth (g1)0.00%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $2,878,800,000.00
- Total debt
- $8,355,100,160.00
- Cash & STI
- $1,284,999,936.00
- Shares out.
- 148,700,000
Overvalued [LOW CF reliability]
Intrinsic value$84.09
Buy price (with MOS)$67.27
Current price$205.02
Discount to intrinsic value-143.8%
7-step quality scorecard
ROE quality
LOW- Average ROE
- 11.9%
- Current ROE
- 7.1%
- Minimum ROE
- 7.1%
Debt quality
CONSERVATIVE- Debt / Equity
- 0.46x
Moat proxy
WEAK_PROXYCash-flow reliability
LOW- Operating CF / Net income
- 3.45x
Technical chart
Confluence: WEAK (1/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- revenueCAGR
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 42.7%
- Public economic interest
- 100.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.